6^th International Conference on Structural Biology August 22-23, 2016 New Orleans, Louisiana, USA

John Miller completed his PhD in biological sciences in 1971 from Stanford University, carried out his postdoctoral research in molecular biology and physiology and at the University of California, San Diego, and then accepted a lectureship at Victoria University of Wellington in 1977. He was promoted to full professor in 2008. He teaches courses in mammalian physiology, cell biology, and development. His research interests are in the mode of action of novel natural products and their development as anticancer agents. He has published more than 113 papers in peer-reviewed journals and has written 4 book chapters.

Mode of action of novel natural products and their development as anticancer agents

R Holland Cheng, Ph D is a Professor of Molecular and Cellular Biology at University of California. Cheng received a master degree in 1989 and a Ph D degree in 1992 from Purdue University. Cheng has served as a Panel Reviewer for NIH programmed project grant, NIH Microbiology & Infectious Diseases Research Committee, NIH National Center for Research Resources, Wellcome Trust, UK and Earth & Life Sciences Council, Netherlands (2002). Cheng has actively served on the advisory board of the International Microscopy Congress plus regional microscopy societies, American Biographical Institute, and International Virus Assembly Symposium.He is also a regular member of the American Chemical Society,American Society for Microbiology and American Biophysical Society. Cheng has published nearly fifty papers in peer reviewed journals and his research mainly focuses on Proteome imaging of macromolecular systems.

Structural biology and proteome imaging of macromolecular systems.

K. Ogata has completed his PhD at the age of 27 years from Yokohama City University in 1992 and postdoctoral studies from RIKEN tsukuba institute. In 1997, He became the leader of the regulation of protein function project, Kanagawa Academy of Science and Technology (KAST), and from 2001, the professor and chairperson of Department of Biochemistry, Yokohama City University Graduate School of Medicine. He has published papers in JMB, PNAS, NSMB, and Cell, and had been serving as an editorial board member of BBRC (2009-2010).

Structural biology, protein function and biochemistry

Seth Pincus received his M.D. from New York University. Following a Pediatrics residency at the University of Utah, he trained in the Immunology Branch of NCI. His first faculty appointment was at the University of Utah, followed by stints at the NIAID Rocky Mountain Labs, at Montana State University where he Chaired the Department of Microbiology, and from there to his current position in the Departments of Microbiology and Pediatrics, at LSU School of Medicine, New Orleans. He has published over 100 peer-reveiwed papers, textbook chapters, and invited articles. He has served on or chaired multiple NIH study sections and editorial boards.

Biologic effects of immunoglobulins and Therapeutic applications of antibodies in infectious diseases

Irena Roterman-Konieczna has completed his PhD at the age of 35 years from Nicolaus Copernicus Medical Academy Krakow, Poland - postdoctoral studies from Cornell University Ithaca NY USA – Harold Scheraga Group. She is the director of Department of Bioinformatics and Telemedicine at Jagiellonian University – Medical College. She has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute. The field of interst is the protein structure and folding simulatioan as well as systems biology. General model for protein folding simulation is published by Woodhead Publishing (currently Elsevier). The model for proteome construction is presented in the book published by Springer. She is the Chief Editor of the journal Bio-Algorithms and Med-Systems (de Gruyter).

Protein structure and folding simulation; Systems biology

Kikuchi has completed his PhD from Osaka City University and postdoctoral studies from Cornell University. Now, he is a professor of Department of Bioinformatics in Ritsumeikan University. Currently, he is interested in developing a new technique to predict 3D structural properties of a protein.

Developing a new technique to predict 3D structural properties of a protein.

G. Sridhar Prasad is the Chief Scientific Officer of CalAsia Pharmaceuticals. He has been the core member of multiple drug discovery teams, including the marketed drug, NESINA (Alogliptin, DPPIV Inhibitor) and clinical candidate MK-4965, for the treatment of HIV-1 AIDS. He obtained his Ph.D., from Indian Institute of Science, Bangalore, India and post-doctoral training at University of Minnesota Medical School and the Scripps Research Institute, La Jolla, California, where he grew to the ranks of Assistant Professor. He has co-authored over 45 peer reviewed research articles, holds six US and international patents. He serves on the editorial board of Current Protein and Peptide Science.

Drug discovery

Dr. Maleki is an expert in food allergy research and has worked in this field for over 18 years. She recieved her Ph.D. from the Univ of Arkansas for Medical Sciences. She has served on the Scientific Advisory Committee to the FDA, the Nataional Peanut Board, and NIH’s Guidelines of the Diagnosis and Management of Food Allergy and as Expert Reviewer for the ($70 million) Canadian AllerGen project. She is a Fellow of the AAAAI and has edited a book and authored over 90 publications, and has had a significant number of invited national and international speaking and reviewer engagements.

Food Processing and Sensory Quality Research